A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Recruiting
Observational Study
Essential Hypertension
Liver Cancer
Nasopharyngeal Cancer
Pancreatic Cancer
Lung Cancer
Chronic Kidney Diseases
Acute Coronary Syndrome
Epilepsy
Gastric Cancer
Primary Aldosteronism
Subclinical hypothyroïdism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 12,000 (estimated)
- Sponsor
- Zhujiang Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to systematically characterize the gut microbiota of various critical chronic diseases, compare the similarities and differences of the microbiome signatures linked to different regions and diseases, and further investigate their impa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. aged 18-75 years;
2. living in the province where the hospital is located in the last three years;
3. with a medical diagnosis of one of the target diseases;
4. willing to provide written informed consent.
Exclusion Criteria:
1. female in pregnancy or lactation(unless the s…
Contacts